A Study on management of organophosphorus poisoning

A STUDY ON THE STATUS OF MANAGEMENT OF ORGANOPHOSPHORUS COMPOUND POISONING REVISITING THE EXISTING CONTROVERSIES THEREIN

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2013/05/003628

Enrollment

120

Registered

2013-05-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Organophosphorus poisoning

Interventions

Intervention1: pralidoxime and atropine therapy as intervention and atropine as comparator: pralidome 0.5-1 gram and atropine 2 mg i.v every 5-10 minutes till the signs of atropinization appeared as i

Eligibility

Inclusion criteria

Inclusion criteria: 1. All consecutive patients, presenting in the emergency department of the hospital during the study period, with history and clinical evidence of organophosphorus (OP) poisoning were screened for eligibility for enrolment. 2. Patients of age between 12 to 65 years and of either sex

Exclusion criteria

Exclusion criteria: 1. Patients who presented more than 24 hours following exposure to OP compounds 2. Patients who had exposed to carbamate.

Design outcomes

Secondary

Measure	Time frame
Duration of hospital stayTimepoint: admission to discharge	—

Primary

Measure	Time frame
MortalityTimepoint: Mortality	—

Countries

India

Contacts

Public ContactDrIndranil Banerjee

Proffesor and Head

tripathi.santanu@gmail.com9230566771

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026